Microarray testing allows high-volume analysis. This work will develop tools for accelerated analysis and modifications to surfaces used within the partner facilities. The goal is to enhance the performance of current assay designs and to inform and guide the next-generation of assay designs (ie 384 well plates) which will support the partner’s technology leadership position. […]

Microarray testing allows high-volume analysis. This work will compare open-source software to in-house analysis methods within SQI Diagnostics. The goal is to enhance the performance of current assay designs and to inform and guide the next-generation of assay designs (ie 384 well plates) which will support SQI’s technology leadership position. After implementing a print run […]

Sepsis, severe pneumonia and respiratory viruses are key causes of Acute Respiratory Distress Syndrome (ARDS)—a detrimental lung condition that results in >3 million ICU admissions/year and can lead to organ failure and death. In Canada, ~18,000 patients with ARDS are admitted to hospital annually and those requiring critical care place an immense burden on hospital […]

Microarray testing allows high-volume analysis. This work will develop tools for accelerated analysis and modifications to surfaces used within the partner facilities. The goal is to enhance the performance of current assay designs and to inform and guide the next-generation of assay designs (ie 384 well plates) which will support the partner’s technology leadership position. […]